Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 979 | 989 | 1013 | 1310 | 1448 | 3459 |
Fund Return | -2.14% | -1.13% | 1.33% | 9.41% | 7.69% | 13.21% |
Place in category | 105 | 153 | 118 | 88 | 75 | 9 |
% in Category | 62 | 92 | 78 | 57 | 57 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Arrowstreet Global Equity Fund | 9.16B | 16.34 | 15.32 | 15.05 | ||
Arrowstreet Global Equity Fund Hedg | 5.53B | 12.19 | 9.83 | 11.95 | ||
Walter Scott Global Equity Fund | 4.9B | 12.31 | 12.56 | 13.46 | ||
Walter Scott Global Equity Fund Hed | 4.9B | 8.72 | 7.56 | 10.71 | ||
Hedged Index Global Infrastructure | 2.56B | 1.92 | 2.90 | 6.95 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard International Shares Inde | 36.96B | 13.98 | 14.48 | 13.52 | ||
Arrowstreet Global Equity Fund | 9.16B | 16.34 | 15.32 | 15.05 | ||
Dimensional Global Core Equity Trus | 7.23B | 13.39 | 13.57 | 11.80 | ||
AMP Capital Specialist Internation | 2.84B | 16.87 | 11.42 | 12.48 | ||
AMP Specialist International Share | 2.84B | 16.84 | 13.09 | 12.90 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nintendo | JP3756600007 | 6.74 | 7,652.0 | +3.28% | |
Novartis | CH0012005267 | 5.90 | 89.50 | -0.56% | |
British American Tobacco | GB0002875804 | 5.37 | 2,326.0 | -0.47% | |
Johnson & Johnson | - | 5.01 | - | - | |
Fox Corp Class A | - | 4.88 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | BUY |
Summary | Strong Sell | Neutral | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review